US Patent 8470329 Combination therapy with antibody-drug conjugates
Patent 8470329 was granted and assigned to Seagen on June, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+202 characters)
Article
Patent abstract
Methods for the treatment of Hodgkin's lymphoma comprising administering both a chemotherapeutic regimen and an antibody-drug conjugate compound to a subject in need thereof are provided.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08470329 Combination therapy with antibody-drug conjugates US Patent 8470329 Combination therapy with antibody-drug conjugates
Infobox
Patent Number
0847032900
Patent Number
847032900
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084703290
Date of Patent
June 25, 2013
0Patent Application Number
135713130
Date Filed
August 13, 2012
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084703290
Date of Patent
June 25, 2013
0Patent Application Number
135713130
Date Filed
August 13, 2012
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08470329 Combination therapy with antibody-drug conjugates
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08470329
Date of patent
June 25, 2013
Patent application number
13571313
Date Filed
August 13, 2012
Patent primary examiner
Find more entities like US Patent 8470329 Combination therapy with antibody-drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.